Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
NPRA:1
Drug Approvals
Ducressa (Dexamethasone 1mg/ml + Levofloxacin 5mg/ml) eye drops, solution
- Approval Date
- Jul 4, 2025
NPRA
Clinical Trials
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
- Conditions
- Pigment Dispersion GlaucomaPrimary Open-angle GlaucomaPrimary Angle-Closure GlaucomaPseudoexfoliation GlaucomaOcular Hypertension
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Santen Pharma Malaysia Sdn Bhd
- Target Recruit Count
- 400
- Registration Number
- NCT04609345
News
No news found